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Abstract
Background: Repeated intracranial hemorrhages caused by cardiac myxoma is very rare. It is essential for physicians to
be aware of such uncommon clinical feature of myxoma.
Case presentation: We report a-49-year-old female patient complained of repeated multiple intracranial hemorrhages,
with no sign of cardiac dysfunction or cerebral infarction before admission. Cavernous angioma (CA) was misdiagnosded
due to the clinical and magnetic resonance (MR) presentation. A sudden ischemic event after admission led to the
finding of a left atrial myxoma.
Conclusions: Repeated intracranial hemorrhages can be the early and primary clinical presentation of cardiac myxoma,
probably caused by its metastasis, without obvious ischemic stroke or cardiac symptoms.
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Background
Cardiac dysfunction often present as the primary com-
plain of atrial myxoma and patients may end up with
sudden death [12]. Without cardiac symptoms, the
variety of clinical features, involving neurologic or cuta-
neous symptoms, could make the diagnosis of atrial
myxoma very difficult [4, 6, 14]. Even up to 10% of pa-
tients with atrial myxoma may not present with any
symptoms [4, 8, 12, 16].
Cardiac myxoma may be found incidentally while
screening the source of intracranial embolus. However,
physicians rarely include atrial myxomas on differential
diagnosis list for intracranial hemorrhages. Thereby, we
would like to present a case of cardiac myxoma inducing
multiple hemorrhagic intracranial lesions mimicking CAs.
Case presentation
A-49-year-old female patient was admitted to local
emergency department in November 2012 and August
2013, suffered from acute headache and dizziness, with-
out any neurologic deficit. No history of hypertension or
familiar CAs was recorded. In both time, Emergency
head Computer Tomography (CT) has showed three
hemorrhagic intracranial lesions in the left parietoccipi-
tal lobe (Fig. 1). Routine head MR scan also showed
three small hemorrhagic lesions, with low signal on
T1-weighted and high signal on T2-weighted images,
without marked enhancement. A significant hypointese
ring outside the lesion represents hemosiderosis, support-
ing diagnosis of CA. No acute infarction was detected in
diffusion weighted imaging (DWI) (Fig. 1). Considering
the good recovery afterwards and the risk of operation,
she accepted the wait-and-see treatment.
In February 2014, she experienced recurrent symp-
toms. This time, she decided to accept intracranial
lesions resection. She was admitted to our hospital in
March 2014 for futher examination and surgical plan
without any complaints of head or chest discomfort at
that time.
In the next morning of hospitalization, she lost con-
sciousness suddenly. Emergent CT indicated the third epi-
sode of hemorrhagic within the lesions. However, after
regaining her consciousness, complete contralateral paraly-
sis, facial palsy and aphasia -without prior seizure-, occured.
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Supportive treatment and intensive monitoring was
initiated for her, and she did not deteriorate. The
Susceptibility Weighted Imaging (SWI) revealed nu-
merous hypointense foci, in addition to the first
known lesions, mimicking CAs in the brain and indi-
cating previous hemorrhages (Fig. 2). Additional DWI
detected multiple minor acute infarction throughout
the left hemisphere, including left basal ganglia, thal-
amus and cortex (Fig. 2).
To identify the cause of embolism, a MR angiography
and echocardiogram was performed. No abnormalities
were detected in the large intracranial arteries by MR
angiography, but a suspicious small aneurysm next to
one of the CA like lesions (Fig. 2). Echocardiogram
Fig. 1 Multiple intracranial hemorrhages detected in head CT scans in this case (Yellow arrows) (a). Head MR scans illustrated hyperintensive
lesions on T2-weighted images, with peripheral hypointensities (Yellow arrows) (b). No marked enhancement was detected in these three lesions
(Yellow arrows) (c). Lesions showed low signals in DWI (Yellow arrows), and no other abnormal signals were found (d)
Fig. 2 After the onset of apsychia, multiple high intensive signals appeared in DWI throughout the left hemisphere (a). A suspicious aneurysm
was detected next to the lesion (b). SWI scan revealed numerous hypointense foci in the whole brain (c)
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demonstrated a 55*28 mm left atrial myxoma, blocking
blood flow through the mitral valve. After several days
of conservative treatment and rehabilitation, she was
able to speak slowly and the muscle strength of the right
limb improved to Grade 4.
During harboring the atrial myxoma, the risk of peri-
operative complications, such as acute cardiac dysfunc-
tion, ischemic stroke or sudden death, are highly
increased. Thus, we cancelled our surgical plan and con-
sulted to the department of cardiac surgery. The patient
was scheduled for atrial myxoma removal after recovery.
The post-operative pathology confirmed the diagnosis of
cardiac myxoma (Fig. 3).
Discussion
Classic presenting manifestations of cardiac myxoma in-
clude constitutional, obstructive, and embolic symptoms
[5]. Cerebral ischemia may be the most significant com-
plaint despite cardiac dysfunction symptoms In patients
with left atrial myxoma, 11%–45% of ischemic strokes
could be induced by a small emboli which is detached
from the myxoma [5, 6]. Cerebral infarction was the
most common manifestation in up to 89% among myx-
oma patients with neurologic symptoms [6]. Therefore,
myxoma is less likely to be ignored in case of repeated
ischemic stroke.
However, only a small fraction of patients with myx-
oma was found due to intracranial hemorrhages [6, 8].
Single hematoma or multiple scattered microbleeds, also
subarachnoid hemorrhage might be present. These hem-
orrhages are usually related to previous cerebral infarc-
tion caused by myxoma [6, 8, 14, 16]. However, it is
quite rare that repeated intracranial hemorrhages
without definitive history of ischemic stroke or cardiac
symptoms, could be the first and primary clinical
presentation. The radiological finding in routine MR im-
aging, especially the hemosiderin signal around the
lesions, strongly support the diagnosis of CA. Therefore,
multiple CAs was misdiagnosed according to the clinical
and MR features before admission.
Even SWI features of this patient imitate CAs. It is
well known that SWI is crucial to diagnose multiple
CAs, because it is very sensitive in detecting previous
microbleeds according to the remaining hemosiderin
with ferromagnetic composition [3, 10]. But in this case,
SWI might be confusing. The presence of hemorrhagic
lesions combined with numerous microbleeds in SWI
indicated multiple CAs. However, considering embolic
stroke afterwards, the visible microbleeds is also likely to
be caused by unnoticed previous minor asymptomatic
lacunar stroke, probably due to micro embolus detached
from cardiac myxoma.
Embolic stroke after admission led us to diagnose car-
diac myxoma eventually. But how did myxoma cause re-
peated hemorrhages without an obvious ischemic stroke
before admission? It was reported that myxomatous
aneurysms might be an alternative source of bleeding
[7, 13, 16]. About 1/3 of patients treated for atrial myx-
oma may present with a cerebral aneurysm [17]. In this
case, the head MR angiography showed a suspicious
aneurysm, but it is not responsible for all hemorrhages ap-
parently. After reviewing previous literatures, it seems that
intracranial hemorrhages of atrial myxoma are relatively
rare, and may be repeated multiple hemorrhages, some
bleeding co-exist with subarachnoid hemorrhage without
angiographic evidence of aneurysms [2, 13]. Another ex-
planation is that cardiac myxoma may break down and
travel along the blood stream, and the metastasis can
bleed inside [11]. In this case, we believe that these intra-
cranial hemorrhagic lesions may be mainly myxoma
metastasis.
Although in this case, the patient did not have irre-
versible poor prognosis after repeated intracranial hem-
orrhages and ischemic event after admission, it should
alert the clinicians to pay more attention to such various
clinical features of myxoma. The repeated hemorrhagic
signals in CT due to myxoma may hinder the clinicians
to make a correct diagnosis of cerebral ischemia.
However, if mxyoma cannot be detected in time, the
hemostatic treatment according to the CT presentation
may exacerbate cerebral ischemia and catastrophic re-
sults, such as acute cardiac dysfunction, ischemic stroke
or sudden death, during anesthesia or around the peri-
operative period. Therefore, cardiac examination, such
as echocardiography, should be performed as an alterna-
tive screening tool for cardiac myxoma, in case of
unclear repeated multiple intracranial hemorrhages,
markedly unmatched symptoms. Especially with un-
matched symptoms.
There are no definite therapeutic guidelines about
further intervention for this disease. Resection of the
Fig. 3 The pathological appearances of resected cardiac myxoma
demonstrated myxiod stroma containing round or fusiform pleomorphic
cells and inflammatory cells (HE staining, original magnification × 5)
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cardiac myxoma firstly is useful to eliminate the original
sources of metastastic lesion, however which cannot
completely abolish the risk of delayed cerebral aneurysm
formation [17]. However, because cerebral aneurysm
from cardiac myxoma are probably multiple and rarely
associated with intracranial hemorrhage, most of the
patients can be managed conservatively [18]. Antifibri-
nolytic drug such as aminomethylbenzoic acid can be
used to prevent rebleeding [13]. If severe intracranial
hemorrhage due to myxoma do occur, excision of large
intracranial hematoma and metastatic lesions remains
supportive, and is useful in eliminating early neurologic
symptoms [13]. For this case, we believe that further
intracranial lesions resection is more suitable than con-
sevative therapy. Some authors also suggest that chemo-
therapy in combination with low-dose radiation for
multiple lesions, but there are only four reported cases
that received 25-60Gy brain radiation in previous studie-
s,and one of these patients died of enlarging intracranial
masses [1, 9, 13, 15].
Conclusions
In summary, the neurosurgical community should be
aware that repeated multiple intracranial hemorrhages
can be the primary cerebral presentation of cardiac myx-
oma, probably due to myxoma metastasis, despite no
significant ischemic stroke for a period. Routine CT, MR
and SWI of intracranial hemorrhagic lesions induced by
cardiac myxoma may mimics CAs. Therefore, cardiac
examination should be performed in case of unusual
multiple intracranial hemorrhages, in order to determine
the presence of cardiac myxoma.
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